Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Rhythm enrols first patient in Phase lll trial of setmelanotide

People living with BBS and Alström Syndrome could experience an insatiable hunger and severe obesity. Credit: Steve Baker.

Go Top